SCHEMBL29915977

SCHEMBL29915977

O=C(NS(=O)(=O)c1ccn[nH]1)c1cccnc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 6/20 0.62
PTGS1 P23219 3/20 0.58
EGFR P00533 2/20 0.58
HDAC1 Q13547 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
CYP3A4 P08684 1/20 0.49
PIM1 P11309 1/20 0.47
PIM3 Q86V86 1/20 0.47
PIM2 Q9P1W9 1/20 0.47
LMNA P02545 2/20 0.47
THRB P10828 1/20 0.47
HIF1A Q16665 1/20 0.47
MAPT P10636 1/20 0.46
ROCK2 O75116 1/20 0.46
ROCK1 Q13464 1/20 0.46
ALDH1A1 P00352 1/20 0.45
NAMPT P43490 1/20 0.45
PRKAB2 O43741 1/20 0.44
PRKAG1 P54619 1/20 0.44
PRKAA2 P54646 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10718560 0.77 PTGS2 (1.00) PTGS2PTGS1EGFRHDAC1HDAC6
SCHEMBL11864560 0.74 HDAC1 (0.66) PTGS2PTGS1EGFRHDAC1HDAC6
SCHEMBL1820805 0.74 HDAC1 (0.66) PTGS2PTGS1EGFRHDAC1HDAC6
SCHEMBL29916100 0.74 PTGS2 (0.60) PTGS2PTGS1EGFRHDAC1HDAC6
SCHEMBL29551608 0.72 PTGS2 (0.66) PTGS2PTGS1EGFRHDAC1HDAC6
SCHEMBL29915998 0.72 PTGS2 (0.58) PTGS2PTGS1EGFRHDAC1HDAC6
SCHEMBL28206469 0.72 PTGS2 (0.58) PTGS2PTGS1EGFRHDAC1HDAC6
Nicoxamat SCHEMBL93839 0.71 HDAC1 (1.00) PTGS2PTGS1HDAC1HDAC6LMNA
SCHEMBL15647894 0.71 PTGS2 (0.83) PTGS2PTGS1EGFRHDAC1HDAC6
SCHEMBL108479 0.71 PTGS2 (0.60) PTGS2PTGS1EGFRHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3798214-B1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2022-09-14 EP claimed